Efficacy of ivabradine in combination therapy for complicated acute coronary syndrome in patients with type 2 diabetes mellitus

Terapevticheskii Arkhiv

Volumn 82, Issue 1, 2010, Pages 27-31

  Kondratyev, A I ^a   Dolgikh, V T ^b   Stotsky, A O ^a  

^a Town Emergency Care Clinical Hospital One   (Russian Federation)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Acute left ventricular failure; Ivabradine; Type 2 diabetes mellitus; Unstable angina

Indexed keywords

ANTIDIABETIC AGENT; BENZAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IVABRADINE; METOPROLOL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; COMPARATIVE STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; ADULT; BENZAZEPINES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METOPROLOL; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 77749258074     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. DiFrancesco D. If current inhibitors: propeties of drug channel interraction. In: Fox K. ed. Selective and specific If channel inhibition in cardiology. London: Science Press Ltd; 2004; vol.5: 1-13.
2. Seccareccia F., Pannozzo F., Dima F. et al. Heart rate as a predictor of mortality: the MATISS Project. Am. J. Publ. Hlth 2001; 91 (7): 1258-1263.
3. Diaz A., Bourassa M. G., Guertin M.-C. et al. Long-term prognostic value of resting heart rate in patients with suspected of proven coronary artery disease. Eur. Heart. J. 2005; 26 (6): 967-974.
4. Kjekshus J. Importance of heart rate in determing beta-blocker efficacy in acute and long-term myocardial infarction intervention trials. Am. J. Cardiol. 1986; 57 (6): 43F-49F.
5. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II-DAVIT-II). Am. J. Cardiol. 1999; 66 (5): 779-785.
6. 9. Mulder P., Barbie S., Chagraoui A. et al. Long-term heart rate reduction induced by the selective If current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004; 109 (6): 1674-1679. (Pubitemid 38451726)
7. Camm A. J., Lau C. P. Electrophysiological effects of a single intravenous administration of ivabradin (S 16257) in adult patient with normal electrophysiology. Drug R&D 2003; 6 (4): 83-89.
8. Lenfant J., Bois P. Selective and specific If inhibition in cardiovascular disease. In: B. N. Singh, P. M. Vanhoutte (eds.) Lippincott Williams and Wilkins; 2003. Phyladelphia p. 79.
9. Bucchi A., Baruscotti M., DiFrancesco D. Current-dependent block of rabbit sino-atrial node If channels by ivabradin. J. Gen Physiol. 2002; 120 (4): 1-13.
10. Monnet X., Colin P., Ghaleh B. et al. Heart rate reduction during exercise-induced myocardial ischemia and stunning. Eur. Heart J. 2004; 25 (9): 579-586.
11. Tardif J. C., Ford I., Tendera M. et al. On behalf of INITIATIVE study investigators group. Antianginal and anti-ischemic effects of the If current inhibitor ivabradine compared to atenolol as monotherapies in patients with chronic stable angina. Eur. Heart J. 2003; 24: Abstr. 186.
12. Vilaine J. P., Bidouard J. P., Lesage L. et al. Anti-ischemic effects of ivabradin, a selective heart-rate reducing agent, in exercise-induced myocardial ischemia in pigs. J. Cardiovasc. Pharmacol. 2003; 42 (5): 688-696.
13. Ruzyllo W., Ford L, Tendera M. et al. Antianginal and antiischemic effects of If current inhibitor ivabradine compared to amlodipine as monotherapy in patients with chronic stable angina: a 3-month randomized, controlled, double-blind, multicenter trial. Eur. Heart J. 2004; 25: A878.
14. Gundersen T., Syekshus J. Timolol treatment after myocardial infarction in diabetic patients. Diabetes Care 1983; 6: 285-290.
15. 20. Lowel H., Koenig W., Engel S. et al. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population -based myocardial infarction register follow-up study. Diabetologia 2000; 43 (2): 218-226. (Pubitemid 30126827)
16. Malmberg K., Herlitz J., Hjalmarson A., Ryden L. Effects of metoprolol on mortality and late infarction in diabetic with suspected acute myocardial infarction. Retrospective data from two large studies. Eur. Heart J. 1989; 10: 423-428.